Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

ResMed Inc (RMD)

  • Business News
  • June 26, 2026, 22:23 UTC
  • 3
  • 1 comments

ResMed Inc. Daily Stock Update

Market reaction Comment Full text

U-HAUL HOLDING CO /NV/ (UHAL)

  • Business News
  • June 26, 2026, 22:21 UTC
  • 8
  • 1 comments

Utah Wildfires: U-Haul Offers 30 Days Free Storage to Evacuees of Iron and Cottonwood Fires

Market reaction Comment Full text

WIPRO LTD (WIT)

  • Business News
  • June 26, 2026, 22:21 UTC
  • 8
  • 1 comments

Capco récompensée par OpenAI pour son innovation et son leadership en matière d’IA responsable

Market reaction Comment Full text

VANECK BITCOIN ETF (HODL)

  • Business News
  • June 26, 2026, 22:20 UTC
  • 6
  • 1 comments

21shares Announces Distributions on TETH, TSOL, THYP, TSUI and TDOT

Market reaction Comment Full text

ADVANCED DRAINAGE SYSTEMS, INC. (WMS)

  • Business News
  • June 26, 2026, 22:13 UTC
  • 6
  • 1 comments

Western Metallica Announces AGM Results

Market reaction Comment Full text

Viridian Therapeutics Inc. (VRDN)

  • Business News
  • June 26, 2026, 22:00 UTC
  • 4
  • 1 comments

Viridian Therapeutics, Inc. - Viridian Therapeutics Announces U.S. FDA Approval and Launch of Lumvoa™ (veligrotug-vvze) for the Treatment of Thyroid Eye Disease

Market reaction Comment Full text

VIRIDIAN THERAPEUTICS, INC.\DE (VRDN)

  • Business News
  • June 26, 2026, 22:00 UTC
  • 31
  • 1 comments

Viridian Therapeutics Announces U.S. FDA Approval and Launch of Lumvoa™ (veligrotug-vvze) for the Treatment of Thyroid Eye Disease

Market reaction Comment Full text

GAMESTOP CORP. (GME)

  • Business News
  • June 26, 2026, 21:45 UTC
  • 6
  • 1 comments

GameStop Provides Fiscal Year 2026 Outlook

Market reaction Comment Full text

INCYTE CORP (INCY)

  • Business News
  • June 26, 2026, 21:38 UTC
  • 6
  • 1 comments

Incyte annuncia lopinione positiva del CHMP per Opzelura® (ruxolitinib) crema per il trattamento della dermatite atopica moderata in pazienti adulti

Market reaction Comment Full text

INCYTE CORP (INCY)

  • Business News
  • June 26, 2026, 21:38 UTC
  • 4
  • 1 comments

Incyte gibt positive Stellungnahme des CHMP zu Opzelura ® (Ruxolitinib)-Creme zur Behandlung von Erwachsenen mit mittelschwerer atopischer Dermatitis bekannt

Market reaction Comment Full text
  • Previous
  • 3781
  • 3782
  • 3783
  • 3784
  • 3785
  • Next

Search

News categories

  • Technical Exchange News(14659)
  • Event(6229)
  • SEC News(392037)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(238901)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin